2
Participants
Start Date
February 4, 2021
Primary Completion Date
June 21, 2021
Study Completion Date
June 21, 2021
MyHOPE™ for Multiple Myeloma
The MyHOPE for MM Platform is designed to provide patients with tools and resources to support them in their overall experience with MM. Patients can share their data through a PDF or by showing their device to their care team at clinic visits.
MyHope HCP Portal
Is designed to provide HCPs with the ability to view patient data and symptom notifications (Cohort 1 only) to provide support between clinic visits and to facilitate dialogue during clinic visits.
Icahn School of Medicine at Mount Sinai, New York
Memorial Sloan Kettering Cancer Center, New York
NY Cancer and Blood Specialists, Port Jefferson Station
Rochester General Hospital - Lipson Cancer Institute, Rochester
Cancer Care Associates of York, York
Jefferson Medical Oncology Associates, Philadelphia
Fox Chase Cancer Center, Philadelphia
American Oncology Partner Maryland, Bethesda
Wake Forest Baptist Health, Winston-Salem
Cone Health Cancer Center, Greensboro
University of North Carolina at Chapel Hill, Chapel Hill
Duke University Medical Center, Durham
Winship Cancer Institute of Emory University, Atlanta
Augusta University - Georgia Cancer Center, Augusta
Mayo Clinic - Jacksonville, Jacksonville
Mitchell Cancer Center, University of South Alabama, Mobile
West Cancer Center, Germantown
Hattiesburg Clinic, Hattiesburg
Cleveland Clinic, Cleveland
Tri County Hematology Oncology, Canton
Fort Wayne Medical Oncology and Hematology, Fort Wayne
Newland Medical Associates, PC, Southfield
Western Michigan Cancer Center, Kalamazoo
Mayo Clinic, Rochester
Oklahoma Cancer Specialists and Research Institute, Tulsa
University of Texas Southwestern Medical Center, Dallas
Community Cancer Trials of Utah, Ogden
Mayo Cliinic - Scottsdale, Scottsdale
James R Berenson MD Inc, West Hollywood
Innovation Clinical Research of the Pacific, Honolulu
University of Arizona, Tucson
Cancer Specialists of North Florida - Jacksonville, Jacksonville
Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston
Lead Sponsor
Amalgam Rx
UNKNOWN
Celgene
INDUSTRY